The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Summer break brings some new concerns for parents, the medical workers helping the nation's aging homeless population, a ...

The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective.

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

Lenacapavir is the second long-acting drug approved to prevent HIV. The first, Apretude, is given every two months and is ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...